Concession Contract for Publishing, Selling and Marketing of the British Pharmacopoeia

MHRA

Value
£47,772,000
Published
14 Sept 2026
Deadline
29 Jan 2027
Procedure
Competitive flexible procedure
Category
79970000 — Publishing services; 79342000 — Marketing services; 72413000 — World wide web (www) site design services
Location
UK, United Kingdom
Notice reference
087063-2026

Requirements summary

The MHRA (Medicines and Healthcare products Regulatory Agency) is planning a concession contract for the publishing, selling and marketing of the British Pharmacopoeia, covering the 2029-2035 editions. The estimated value is GBP 39.81m net (GBP 47.772m gross), with a planned contract period from 31 March 2027 to 31 March 2032, extendable by two 12-month renewals to a maximum of 31 March 2034. The procurement uses a two-stage competitive flexible procedure with delivery across the UK.

Key requirements

  • Publish, sell and market British Pharmacopoeia editions covering 2029-2035
  • Concession contract with estimated value of GBP 39.81m net (GBP 47.772m gross)
  • Contract period 31 March 2027 to 31 March 2032, with up to two 12-month renewals (maximum end 31 March 2034)
  • Two-stage competitive flexible procedure; further details via pre-market engagement webinars
  • Electronic submissions in English; tender period closes 29 January 2027
  • Delivery across the United Kingdom; SME participation suitable
Concession Contract for Publishing, Selling and Marketi… | ProposAI